| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.05 | 0.4 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.054 | 0.4 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |